CCND1 and T-cell leukemia: These results are consistent with the report that AZD8055 induces G0/G1 cell cycle arrest, reduces cyclin D1, and increases p27 expression in colon cancer cells [22], adult T-cell leukemia cell lines [23], and T cells [24].